Read articles from Europe

September 28, 2026 by theolivepress.es

Spain’s new anti-smoking law shows how easily tobacco control can expand from protecting bystanders to restricting every nicotine product in the same breath. Smoke-free spaces, youth protection and advertising rules all deserve serious attention, but policy loses precision when cigarettes, vapes and heated tobacco are treated as one problem. The goal should be less smoking and less exposure to harmful emissions, not a framework that blurs the difference between combustion and lower-risk alternatives. Strong regulation works best when it understands what it is regulating.

September 25, 2026 by planetofthevapes.co.uk

Pet safety brings the vaping debate down to everyday responsibility. E-liquids, nicotine pouches and devices need to be stored properly, kept away from animals and treated as products that require care in the home. That message is far more useful than panic: risk can be reduced through clear guidance, safer handling and responsible use. Harm reduction should include honest information about protecting everyone in the environment, including pets.

September 25, 2026 by planetofthevapes.co.uk

Pet safety brings the vaping debate down to everyday responsibility. E-liquids, nicotine pouches and devices need to be stored properly, kept away from animals and treated as products that require care in the home. That message is far more useful than panic: risk can be reduced through clear guidance, safer handling and responsible use. Harm reduction should include honest information about protecting everyone in the environment, including pets.

September 24, 2026 by gfn.tv

France has chosen to close the door on nicotine pouches, but the demand they answered will not vanish with the ban. Adult smokers and nicotine users may now be pushed towards cross-border purchases, informal supply or the one product still widely available: cigarettes. That is the weakness of treating smoke-free alternatives as threats instead of regulating them as part of a risk hierarchy. The real test comes next — whether the ban reduces harm, or simply moves it somewhere less visible.

September 24, 2026 by substack.com

Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.

September 24, 2026 by c2cjournal.ca

Zero tolerance sounds clean until it meets real life. People do not stop wanting nicotine because policy declares the end of nicotine; they move towards whatever remains available, affordable and believable. That can mean illicit markets, continued smoking or mistrust of public health advice that refuses to distinguish between risk levels. A strategy built on eliminating nicotine may backfire unless it first deals honestly with why safer alternatives exist.

September 24, 2026 by c2cjournal.ca

Zero tolerance sounds clean until it meets real life. People do not stop wanting nicotine because policy declares the end of nicotine; they move towards whatever remains available, affordable and believable. That can mean illicit markets, continued smoking or mistrust of public health advice that refuses to distinguish between risk levels. A strategy built on eliminating nicotine may backfire unless it first deals honestly with why safer alternatives exist.

September 23, 2026 by substack.com

Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.

September 23, 2026 by 2firsts.com

A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.